Exploiting Chromosomal Instability of PTEN-Deficient Triple-Negative Breast Cancer Cell Lines for the Sensitization against PARP1 Inhibition in a Replication-Dependent Manner
Autor: | Sandra Classen, Alexandra Zielinski, Kerstin Borgmann, Harriet Wikman, Felix Meyer, Ann Christin Parplys, Cordula Petersen, Johanna Rieckhoff, Kai Rothkamm, Britta Riepen |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Cancer Research PTEN Tumor suppressor gene replication stress lcsh:RC254-282 Article 03 medical and health sciences 0302 clinical medicine PARP1 Chromosome instability PARP1 inhibition medicine Tensin CIN replication fork instability Triple-negative breast cancer biology Cancer medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Chromatin 030104 developmental biology Oncology 030220 oncology & carcinogenesis Cancer research biology.protein TNBC |
Zdroj: | Cancers Volume 12 Issue 10 Cancers, Vol 12, Iss 2809, p 2809 (2020) |
ISSN: | 2072-6694 |
DOI: | 10.3390/cancers12102809 |
Popis: | Simple Summary The poor prognosis of patients with TNBC have fostered a major effort to identify more patients who would benefit from targeted therapies. Here we recognize PTEN as a potential CIN-causing gene in TNBC and consider PTEN-deficient TNBC for the treatment with PARP1 inhibitors due to the protective role of PTEN during DNA replication. Abstract Chromosomal instability (CIN) is an emerging hallmark of cancer and its role in therapeutic responses has been increasingly attracting the attention of the research community. To target the vulnerability of tumors with high CIN, it is important to identify the genes and mechanisms involved in the maintenance of CIN. In our work, we recognize the tumor suppressor gene Phosphatase and Tensin homolog (PTEN) as a potential gene causing CIN in triple-negative breast cancer (TNBC) and show that TNBC with low expression levels of PTEN can be sensitized for the treatment with poly-(ADP-ribose)-polymerase 1 (PARP1) inhibitors, independent of Breast Cancer (BRCA) mutations or a BRCA-like phenotype. In silico analysis of mRNA expression data from 200 TNBC patients revealed low expression of PTEN in tumors with a high CIN70 score. Western blot analysis of TNBC cell lines confirm lower protein expression of PTEN compared to non TNBC cell lines. Further, PTEN-deficient cell lines showed cellular sensitivity towards PARP1 inhibition treatment. DNA fiber assays and examination of chromatin bound protein fractions indicate a protective role of PTEN at stalled replication forks. In this study, we recognize PTEN as a potential CIN-causing gene in TNBC and identify its important role in the replication processes. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |